Skip to search formSkip to main contentSkip to account menu

PF 04217329

Known as: PF-04217329, PF04217329 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Purpose: To evaluate the safety of escalating doses of taprenepag isopropyl (PF-04217329), a selective EP2 receptor agonist…